LAB Standard BioTools Inc: Tanggungan utang jangka dawa perusahaan

Simbol resmi perusahaan Fluidigm (LAB)

Standard BioTools Inc. (LAB) specializes in diagnostic laboratory research. This chart of share prices on GURU.Markets reflects the impact of high demand for external shipments of boards and lasers, with the indicator standing at 0.02. New top management is currently optimizing expenses, prioritizing the most profitable instruments. Additionally, the business is implementing energy-saving technologies and reducing toxic emissions at its production facilities.

LAB (fluidigm.com) riwayat Utang jangka dawa perusahaan saka 28.04.2023 nganti 28.10.2026

Rincian analitis perusahaan Fluidigm (LAB)

- rega lan prakiraan konsensus rega:
Rega saham fluidigm.com|LAB - Bagan rega target
- data kapitalisasi pasar:
Kapitalisasi pasar Standard BioTools|LAB - Nilai Perusahaan
- data kapitalisasi buku:
Nilai Buku saben Saham Standard BioTools|LAB - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku fluidigm.com|LAB - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Utang marang Modal Standard BioTools Inc.|LAB - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Standard BioTools Corp|LAB - Gunggung utang perusahaan|Utang-utang marang aset resik Standard BioTools|LAB - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Standard BioTools
Analisis umum perusahaan:fluidigm.com (LAB)
Produk sing diprodhuksi Standard BioTools Inc.

Conservative capital demands absolute transparency regarding debt load to assess business resilience amid tight monetary policy. This indicator measures the cost of long-term debt obligations, allowing for a comparison between the cost of capital and operating liquidity. The modernization of assembly lines and the upgrading of calibration systems at Standard BioTools Inc. (LAB) confirm the targeted use of funds, as reflected in the company's long-term debt dynamics.

Perusahaan pesaing

agilent.com - Utang jangka dawa perusahaan|Quest Diagnostics Incorporated (DGX) - Utang jangka dawa perusahaan|ILMN - Tanggungan utang jangka dawa perusahaan|EXAS: Utang jangka dawa perusahaan|RVTY (Revvity Corp) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Bio-Rad Laboratories|Utang jangka dawa perusahaan anbio.com (NNNN)|Sotera Health - Kewajiban jangka dawa perusahaan|Utang jangka dawa QDEL (Quidel Corporation)|Utang jangka dawa perusahaan OPK|Gunggunge utang jangka dawa CareDx CDNA|Utang jangka dawa perusahaan MRVI (Maravai LifeSciences)|FLGT: Gunggunge utang jangka dawa|Cytek Biosciences - Utang jangka dawa perusahaan|OSUR (OraSure Technologies, Inc.) - Gunggunge utang jangka dawa|XGN: Utang jangka dawa perusahaan|Gunggunge utang jangka dawa MDxHealth, Inc. (MDXH)|Kewajiban jangka dawa perusahaan Lucid Diagnostics Inc.|Gedhene kewajiban jangka dawa prenetics.com (PRE)|Utang jangka dawa perusahaan IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech PLC - Utang jangka dawa perusahaan|ProPhase (PRPH) - Utang jangka dawa perusahaan|AIMD - Tanggungan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Co-Diagnostics, Inc.|heartsciences.com (HSCS) - Tanggungan utang jangka dawa perusahaan|BMRA (Biomerica) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan CDIO|Virax Biolabs Group Ltd (VRAX) - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan Bluejay Diagnostics Corp (BJDX)|AWH - Utang jangka dawa perusahaan|AXDX - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan CENTOGENE (CNTG)|ENZ - Silihan lan utang jangka dawa perusahaan|fresh2.co (FRES) - Utang jangka dawa perusahaan|Genetic Technologies Limited (GENE) - Utang jangka dawa perusahaan|ME: Utang jangka dawa perusahaan|Gunggunge utang jangka dawa PMD